Evidence map›Paper›PMID 33430979›Full record

ArticleJournal of cheminformatics2019

Learning important features from multi-view data to predict drug side effects.

Xujun Liang, Pengfei Zhang, Jun Li, Ying Fu, Lingzhi Qu, Yongheng Chen, Zhuchu Chen

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xujun LiangNHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, XiangYa Road, Changsha, China. liangrandn@gmail.com.ORCID http://orcid.org/0000-0003-1698-5193
Pengfei ZhangNHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, XiangYa Road, Changsha, China.
Jun LiNHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, XiangYa Road, Changsha, China.
Ying FuNHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, XiangYa Road, Changsha, China.
Lingzhi QuNHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, XiangYa Road, Changsha, China.
Yongheng ChenNHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, XiangYa Road, Changsha, China.
Zhuchu ChenNHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, XiangYa Road, Changsha, China.

Funding

National Natural Science Foundation of Hunan Province No. 2018JJ3807
6 · The paper itself

Abstract

The problem of drug side effects is one of the most crucial issues in pharmacological development. As there are many limitations in current experimental and clinical methods for detecting side effects, a lot of computational algorithms have been developed to predict side effects with different types of drug information. However, there is still a lack of methods which could integrate heterogeneous data to predict side effects and select important features at the same time. Here, we propose a novel computational framework based on multi-view and multi-label learning for side effect prediction. Four different types of drug features are collected and graph model is constructed from each feature profile. After that, all the single view graphs are combined to regularize the linear regression functions which describe the relationships between drug features and side effect labels. L1 penalties are imposed on the regression coefficient matrices in order to select features relevant to side effects. Additionally, the correlations between side effect labels are also incorporated into the model by graph Laplacian regularization. The experimental results show that the proposed method could not only provide more accurate prediction for side effects but also select drug features related to side effects from heterogeneous data. Some case studies are also supplied to illustrate the utility of our method for prediction of drug side effects.

Indexed as

Feature selectionHeterogeneous data integrationSide effect prediction

Identifiers

PMID33430979
PMCPMC6916463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.